Abstract
The complex diseases in the field of Neurology, Cardiology and Oncology have the most important impact on our society. The theoretical methods are fast and they involve some efficient tools aimed at discovering new active drugs specially designed for these diseases. The ontology of all the items that are linked with the molecule metabolism and the treatment of these diseases gives us the possibility to correlate information from different levels and to discover new relationships between complex diseases such as common drug targets and disease patterns. This review presents the ontologies used to process drug discovery and design in the most common complex diseases.
Keywords: Drug design, ontology, prostaglandin synthases, complex disease, Alzheimer, ’, s disease, Parkinson, multi-factorial diseases, Drug Discovery Investigations ontology (DDI), Protein Modification (PSI-MOD), Protein Ontology (PRO), National Drug Data File (NDDF), Drug Interaction Ontology (DIO), NCI Thesaurus (NCI-T), SNOMED-CT, RxNorm, NDF, EBI, (ICD-NA)
Current Pharmaceutical Design
Title: Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Volume: 16 Issue: 24
Author(s): Jose M. Vazquez-Naya, Marcos Martinez-Romero, Ana B. Porto-Pazos, Francisco Novoa, Manuel Valladares-Ayerbes, Javier Pereira, Cristian R. Munteanu and Julian Dorado
Affiliation:
Keywords: Drug design, ontology, prostaglandin synthases, complex disease, Alzheimer, ’, s disease, Parkinson, multi-factorial diseases, Drug Discovery Investigations ontology (DDI), Protein Modification (PSI-MOD), Protein Ontology (PRO), National Drug Data File (NDDF), Drug Interaction Ontology (DIO), NCI Thesaurus (NCI-T), SNOMED-CT, RxNorm, NDF, EBI, (ICD-NA)
Abstract: The complex diseases in the field of Neurology, Cardiology and Oncology have the most important impact on our society. The theoretical methods are fast and they involve some efficient tools aimed at discovering new active drugs specially designed for these diseases. The ontology of all the items that are linked with the molecule metabolism and the treatment of these diseases gives us the possibility to correlate information from different levels and to discover new relationships between complex diseases such as common drug targets and disease patterns. This review presents the ontologies used to process drug discovery and design in the most common complex diseases.
Export Options
About this article
Cite this article as:
M. Vazquez-Naya Jose, Martinez-Romero Marcos, B. Porto-Pazos Ana, Novoa Francisco, Valladares-Ayerbes Manuel, Pereira Javier, R. Munteanu Cristian and Dorado Julian, Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389199
DOI https://dx.doi.org/10.2174/138161210792389199 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nutrient and Qualitative Phytochemical Analysis-evaluation of Antimicrobial Activity and Development of Products with Mulberry Leaves (<i>Mulberry indica</i> L.)
Current Nutrition & Food Science The J-shaped Association Between Alcohol Consumption and Breast Cancer: A Case-Control Study
Current Nutrition & Food Science Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in HIV Patients: Rationale for Preventative Measures
Current Medicinal Chemistry Gestational Programming of Offspring Obesity: A Potential Contributor to Alzheimers Disease
Current Alzheimer Research Cardiac Monitoring in Patients with Syncope: Making that Elusive Diagnosis
Current Cardiology Reviews Editorial from Guest Editors [Hot Topic: Children with Congenital Heart Disease (Guest Editors: Kris De Boeck and Tony Reybrouck)]
Current Respiratory Medicine Reviews Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance
Current Pharmaceutical Design Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Current Neurovascular Research Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer’s Disease: A Phase 2, Open-Label Extension Study
Current Alzheimer Research Effects of Structured Treatment Interruptions on Metabolic, Anthropometric, Immunologic, and Quality of Life Outcomes in HIV-Positive Adults on HAART
Current HIV Research Statins and Metabolism of High Density Lipoprotein
Cardiovascular & Hematological Agents in Medicinal Chemistry Choosing a Revascularization Strategy in Patients with Diabetes and Stable Coronary Artery Disease: A Complex Decision
Current Cardiology Reviews Cytokine Gene Variants as Predictors of Type 2 Diabetes Mellitus
Current Diabetes Reviews Tachykinins and Neuropsychiatric Disorders
Current Drug Targets Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients
Current Pharmaceutical Biotechnology Fish Oils and Vascular Disease Prevention: An Update
Current Medicinal Chemistry Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology Sarcolemmal K<sub>ATP</sub> Channel Modulators and Cardiac Arrhythmias
Current Medicinal Chemistry Cardiovascular Disease in the Systemic Vasculitides
Current Vascular Pharmacology